Castle Biosciences, Inc. (CSTL)
NASDAQ: CSTL · Real-Time Price · USD
39.40
-0.70 (-1.73%)
Dec 26, 2025, 4:00 PM EST - Market closed
Castle Biosciences Market Cap
Castle Biosciences has a market cap or net worth of $1.15 billion as of December 26, 2025. Its market cap has increased by 38.56% in one year.
Market Cap
1.15B
Enterprise Value
899.48M
1-Year Change
38.56%
Ranking
Category
Stock Price
$39.40
Market Cap Chart
Since July 25, 2019, Castle Biosciences's market cap has increased from $123.05M to $1.15B, an increase of 834.48%. That is a compound annual growth rate of 41.58%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 26, 2025 | 1.15B | 54.06% |
| Dec 31, 2024 | 746.39M | 28.53% |
| Dec 29, 2023 | 580.73M | -6.38% |
| Dec 30, 2022 | 620.32M | -43.76% |
| Dec 31, 2021 | 1.10B | -32.00% |
| Dec 31, 2020 | 1.62B | 176.41% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Jul 25, 2019 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 965.00B |
| Johnson & Johnson | 500.24B |
| AbbVie | 406.46B |
| UnitedHealth Group | 300.58B |
| AstraZeneca | 286.29B |
| Novartis AG | 267.64B |
| Merck & Co. | 265.03B |
| Novo Nordisk | 232.28B |